Intensive care management of the patient with cystic fibrosis

Ted M Kremer1, Robert G Zwerdling, Peter H Michelson

  • 1Department of Pediatrics, University of Massachusetts Medical Center, Worcester, Massachusetts 01655, USA. kremert@ummhc.org

Insights

Cystic fibrosis (CF) patients now live into adulthood due to improved therapies. This article guides intensive care physicians on managing CF complications and end-of-life care for adult CF patients.

Area of Science:

  • Pulmonology
  • Critical Care Medicine
  • Genetics

Background:

  • Cystic fibrosis (CF) was historically a pediatric disease.
  • Therapeutic advancements have significantly increased patient lifespan into adulthood.
  • Adult CF patients present unique challenges in intensive care settings.

Purpose of the Study:

  • To educate intensive care unit (ICU) physicians on adult cystic fibrosis care.
  • To outline ICU-specific complications in cystic fibrosis patients.
  • To provide current clinical management recommendations for adult CF patients.

Main Methods:

  • Review of current literature on cystic fibrosis management.
  • Analysis of common ICU complications in cystic fibrosis.
  • Synthesis of evidence-based recommendations for intensivist care.

Main Results:

  • Pulmonary decline due to obstruction, infection, and inflammation is a primary concern.
  • Non-pulmonary organ involvement (liver, pancreas, intestines, kidneys) requires careful consideration.
  • Lung transplantation is an option, but post-transplant survival varies.

Conclusions:

  • Adult cystic fibrosis patients require specialized ICU management.
  • Multisystem complications necessitate a comprehensive approach.
  • Palliative and end-of-life care planning is crucial for patient and family support.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...